It’s time to call BS.

It’s time to call BS.

Later this afternoon at 2:15 PST Embecta will present and tells us all about their way cool whiz bang patch pump for patients with Type 2 diabetes that they just submitted to the FDA. They will tell us how large and underpenetrated the market is and how new solutions are needed. What they won’t tell us is how they plan to compete with patch pump and insulin pump market leader Insulet. Nor will they tell us how they will compete with all the other OmniPod wannabes.

Speaking of which it’s time to call out BULLSHIT and . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.